These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3546146)

  • 1. Efficacy of ofloxacin (HOE 280) in a model of subcutaneous abscess: penetration and prevention of abscess formation.
    García Iglesias MC; Perea EJ
    Infection; 1986; 14 Suppl 4():S266-9. PubMed ID: 3546146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE; Gyssens IC; Goessens WH; Mouton JW; Oyen WJ; van der Meer JW; Verbrugh HA
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice.
    Fujimoto T; Sato M; Katami K; Osada Y; Tsumura M; Tachizawa H; Une T
    Chemotherapy; 1986; 32(3):291-8. PubMed ID: 3458566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots.
    Hau T; Jacobs DE; Hawkins NL
    Arch Surg; 1986 Feb; 121(2):163-8. PubMed ID: 3511886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro susceptibility and in-vivo efficacy of antimicrobials in the treatment of intraabdominal sepsis in mice.
    Brook I; Gillmore JD
    J Antimicrob Chemother; 1993 Mar; 31(3):393-401. PubMed ID: 8486573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA; Quinto J; Kao J; Rotstein OD
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator.
    Rotstein OD; Kao J
    J Infect Dis; 1988 Oct; 158(4):766-72. PubMed ID: 3139778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and systemic metabolic responses to aerobic and anaerobic intra-abdominal abscesses in a highly reproducible chronic rat model.
    Nakatani T; Sato T; Marzella L; Hirai F; Trump BF; Siegel JH
    Circ Shock; 1984; 13(3):271-94. PubMed ID: 6380793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia.
    Vary TC; Siegel JH; Tall B; Morris JG
    J Trauma; 1989 Jul; 29(7):1003-13; discussion 1013-4. PubMed ID: 2664200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative model for subcutaneous abscess formation in mice.
    Joiner KA; Onderdonk AB; Gelfand JA; Bartlett JG; Gorbach SL
    Br J Exp Pathol; 1980 Feb; 61(1):97-107. PubMed ID: 6990956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Escherichia coli lipopolysaccharide on Bacteroides fragilis abscess formation and mortality in mice.
    Tanaka Y; Jotwani R; Watanabe K; Tanaka K; Kato N; Ueno K
    Microbiol Immunol; 1994; 38(2):97-102. PubMed ID: 8041306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
    Beale AS; Gisby J
    Infection; 1991; 19(2):101-5. PubMed ID: 2050417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of glucan and cefoxitin in prevention of murine abscess.
    Hull CC; Stellato TA; Rhodes RS; Galloway P; Hawkins NL
    Curr Surg; 1986; 43(5):416-8. PubMed ID: 3533446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.